SCHEMBL24223102

SCHEMBL24223102

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(-c5ccc(-c6cc7ccc8ccccc8c7c7sc8ccccc8c67)cc5)cc4)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ NQO2 P16083 2/20 0.36
▸ NQO1 P15559 1/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ LIMK1 P53667 3/20 0.34
▸ TNKS O95271 1/20 0.33
▸ TNKS2 Q9H2K2 1/20 0.33
▸ F9 P00740 1/20 0.33
▸ ALOX5 P09917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24029159 0.95 NQO2 (0.36) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24029155 0.95 NQO2 (0.36) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24028760 0.95 NQO2 (0.36) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24028942 0.94 KDM4E (0.37) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24223112 0.94 MAPT (0.44) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24028505 0.93 NQO1 (0.35) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24028768 0.92 NQO2 (0.38) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24028495 0.92 KDM4E (0.34) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24028503 0.92 KDM4E (0.34) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24028939 0.91 NQO2 (0.36) MAPTKDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220024948-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-01-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024948-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MAPT 1857/4885KDM4E 2496/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback